ALPL rs34810399: Understanding Carrier Status and Hypophosphatasia
The rs34810399 variant is a specific change located within the ALPL gene, which provides instructions for producing the tissue-nonspecific alkaline phosphatase enzyme. This variant is recognized as a marker for carrier status in relation to hypophosphatasia, a rare metabolic disorder that affects bone mineralization.
What each genotype means
Typical ALPL genotype
This is the most common genotype for this position in the ALPL gene. It is considered the reference sequence and is not associated with the rare metabolic bone disorder hypophosphatasia.
This is the most frequent genotype observed across global populations.
Carrier of ALPL variant
You carry one copy of the A allele, which is associated with hypophosphatasia. While this variant is linked to the condition, carriers may be asymptomatic or experience mild symptoms; clinical presentation is highly variable and not guaranteed.
This genotype is rare in the general population.
Associated with hypophosphatasia risk
You carry two copies of the A allele, which is associated with hypophosphatasia, a rare disorder affecting bone and tooth mineralization. Because this condition has variable penetrance, you should discuss these results with a healthcare provider to understand if any clinical monitoring is appropriate for your health history.
This genotype is very rare in the general population.
What is the rs34810399 Variant?
The rs34810399 variant is a single nucleotide polymorphism (SNP) found within the ALPL gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is cataloged by researchers because it is associated with the function of the ALPL gene. When a variant is identified as a carrier status marker, it means that an individual possesses one copy of the altered gene, which may not cause symptoms in the carrier but could be relevant if passed on to offspring. Because rs34810399 is considered rare, it is not typically found in the general population at high frequencies. Understanding where this variant sits on the chromosome and how it alters the genetic code is a primary focus for clinical geneticists studying metabolic bone health.
The Role of the ALPL Gene
The ALPL gene is responsible for encoding the tissue-nonspecific alkaline phosphatase (TNSALP) enzyme. This enzyme is essential for the body's ability to mineralize bones and teeth properly. TNSALP acts as a phosphohydrolase, meaning it helps break down certain phosphate-containing molecules that would otherwise inhibit the formation of hydroxyapatite, the mineral component of bone. When the ALPL gene contains pathogenic variants, the resulting TNSALP enzyme may have reduced activity or stability. This deficiency leads to the accumulation of substrates that interfere with normal skeletal development and maintenance. Because the enzyme is expressed in various tissues, including the liver, kidneys, and bones, the clinical impact of ALPL variants can be diverse, ranging from asymptomatic biochemical changes to severe skeletal abnormalities.
Research and Clinical Associations
Research into ALPL variants, including rs34810399, is primarily focused on its link to hypophosphatasia (HPP). HPP is a rare, inherited metabolic disorder characterized by defective bone mineralization. The evidence linking specific ALPL variants to HPP is generally considered moderate to strong, depending on the functional impact of the mutation on the TNSALP enzyme. Studies often use in vitro assays to measure how much enzyme activity is lost when a specific variant is present. Some variants exhibit a 'dominant-negative effect,' where the altered protein interferes with the function of the normal protein produced by the other copy of the gene. While many carriers of a single pathogenic ALPL variant remain asymptomatic, they may show biochemical signs, such as low serum alkaline phosphatase levels. Clinical interpretation of these variants is complex and requires careful correlation with a patient's medical history and biochemical profile.
Interpreting Your Genetic Information
If you have received information regarding your status for rs34810399, it is important to understand that this is not a medical diagnosis. Genetic testing for rare variants can provide insights into your carrier status, but it does not predict the presence or severity of a disease on its own. Because hypophosphatasia can be inherited in both autosomal recessive and autosomal dominant patterns, the clinical significance of a single variant depends on the broader genetic context and the specific nature of the mutation. You cannot use this information to self-diagnose or make decisions about medical treatments. If you are concerned about your bone health or family history, you should discuss these results with a qualified healthcare provider or a genetic counselor. They can help interpret the findings in the context of your overall health and determine if further clinical evaluation is necessary.
How common is this variant?
The rs34810399 variant is classified as rare in the general population, with specific allele frequencies varying significantly across different ancestral groups.
Frequently asked questions
What is hypophosphatasia?
Hypophosphatasia is a rare genetic disorder that prevents proper bone mineralization, often caused by mutations in the ALPL gene. It can lead to weak bones, dental issues, and other skeletal problems.
Does being a carrier mean I have the disease?
Being a carrier typically means you have one copy of a variant that could be associated with a condition, but you may not show symptoms. However, some ALPL variants can cause mild symptoms even in carriers.
Should I be worried if I have this variant?
Finding a variant does not mean you have a disease. You should consult with a doctor or genetic counselor to understand what this result means for your specific health situation.
How is hypophosphatasia diagnosed?
Diagnosis is usually based on a combination of clinical symptoms, biochemical testing (like measuring alkaline phosphatase levels), and genetic testing to identify pathogenic variants in the ALPL gene.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs34810399?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29